Drugs Made In America Acquisition Corp. · NASDAQ:DMAA
Glazer Capital, LLC's stake in Drugs Made In America Acquisition Corp. fell to 4.12% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Glazer Capital, LLC's stake in Drugs Made In America Acquisition Corp. fell to 4.12%, 999,899 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 4.12%
- Shares
- 999,899
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Glazer Capital, LLC | 4.12% | 999,899 |
| Paul J. Glazer | 4.12% | 999,899 |
Source
Related
- Drugs Made In America Acquisition Corp.
- Glazer Capital, LLC
- Drugs Made In America Acquisition Corp. shareholders
- Schedule 13G · Glazer Capital, LLC · May 15, 2025
- Schedule 13G/A · Karpus Management, Inc. · Aug 14, 2026
- Schedule 13G/A · First Trust Capital Management L.P. · Aug 14, 2026
- Schedule 13G/A · Mizuho Financial Group Inc · Aug 13, 2026
- Schedule 13G · Feis Equities LLC · Jun 26, 2026
- Schedule 13G · Mizuho Financial Group Inc · May 14, 2026